The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.

AusPAR: Linagliptin / Metformin HCl

Australian Public Assessment Report

AusPAR

AusPAR: Linagliptin / Metformin HCl [PDF, 979.06 KB]

AusPAR: Linagliptin / Metformin HCl [Word, 1.51 MB]

Attachment: Product Information: Linagliptin / Metformin HCl [PDF, 217.36 KB]

Attachment: Product Information: Linagliptin / Metformin HCl [Word, 90.7 KB]

Attachment: Extract from Clinical Evaluation Report: Linagliptin / Metformin HCl [PDF, 1.73 MB]

Attachment: Extract from Clinical Evaluation Report: Linagliptin / Metformin HCl [Word, 3.65 MB]

Device/Product Name

Trajentamet

Active ingredients

Linagliptin / Metformin HCl

AusPAR Date

26 September 2013

Published

23 October 2013

Submission Number

PM-2011-03536-3-5

Submission Type

New fixed combination

Decision

Approved